Clearance Summary
Myo Plus received FDA 510(k) clearance under submission number K191179, sponsored by Otto Bock Healthcare Products GmbH. The device was reviewed via the Traditional premarket notification pathway and assigned to the Neurology review panel. The statutory decision date of record is 2019-09-04.
- Submission: K191179
- Applicant / Sponsor: Otto Bock Healthcare Products GmbH
- Clearance pathway: Traditional
- Review panel: Neurology
- Device class: Class II
- Regulation citation: 21 CFR 882.1320
- Decision date: 2019-09-04
Classification & Regulation
This clearance is catalogued under FDA product code GXY and 21 CFR 882.1320, within the Neurology review panel as a Class II device.